Frazier Life Sciences Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-600,000
| Closed | -$8.71M | – | 55 |
|
|
2023
Q3 | $8.71M | Sell |
600,000
-3,108,838
| -84% | -$45.1M | 0.58% | 32 |
|
|
2023
Q2 | $77.6M | Hold |
3,708,838
| – | – | 4.64% | 8 |
|
|
2023
Q1 | $78.3M | Hold |
3,708,838
| – | – | 5.67% | 6 |
|
|
2022
Q4 | $94.4M | Buy |
3,708,838
+296,000
| +9% | +$7.53M | 5.87% | 6 |
|
|
2022
Q3 | $82M | Buy |
3,412,838
+217,435
| +7% | +$5.22M | 6.31% | 5 |
|
|
2022
Q2 | $61.5M | Hold |
3,195,403
| – | – | 5.8% | 6 |
|
|
2022
Q1 | $55.5M | Buy |
+3,195,403
| New | +$55.5M | 4.73% | 8 |
|